超临界流体技术制备5-氟尿嘧啶-吲哚美辛-聚乳酸缓释微球

Preparation of 5-fluorouracil indomethacin poly(L-lactide) microspheres using a novel supercritical fluid technique

  • 摘要: 为了考察药物5-氟尿嘧啶(5-Fu)与吲哚美辛(IDMC)的协同作用, 采用超临界流体强制分散溶液技术(SEDS), 以二氯甲烷/二甲亚砜为共溶剂, 制备了复合5-Fu和IDMC的L-聚乳酸(PLLA)微球。利用单因素法探索了制备复合微球的最佳外部条件, 通过表面形貌、 载药量、 粒径分布、 释放性能的检测和体外细胞实验来表征微球的各项性能。结果表明: 当共溶剂二氯甲烷/二甲亚砜比例为30∶1时, 制备该微球的优化条件为39℃、 14MPa; 微球形貌呈类球形, 粒径分布在0.5~5μm; 复合IDMC后微球具有更优良的缓释效果; 载药微球对A549细胞系增殖有明显的抑制作用, 但与复合IDMC前后微球共培养的2组细胞的相对生长速率(RGR)无显著性差异。

     

    Abstract: To investigate the synergistic effect of the drug 5-fluorouracil(5-Fu) and indomethacin(IDMC), the microspheres of poly(L-lactide) with IDMC and 5-Fu were prepared by the technique of solution-enhanced dispersion by supercritical CO2 (SEDS), using dichloromethane/dimethyl sulfoxide as a cosolvent system. A single factor method was used to explore the best external conditions. The morphology, drug loading, particle size distribution and release profiles of 5-Fu-IDMC-PLLA microspheres were characterized, and the in vitro cell culture was designed and performed. The results indicate that 39℃, 14MPa is the preferable condition for the microspheres preparation when the ratio of the cosolvent is 30∶1. The microspheres exhibite a good spherical morphology, a particle size distribution between 0.5~ 5μm, which possess a sustained-release property and enhanced after composited with IDMC. The in vitro cell culture experiment show that the drug-loaded microspheres significantly inhibite the proliferation of A549 cell line, but the relative growth rate (RGR) of the two group of cells cultured with the microspheres before and after composition IDMC have no significant difference.

     

/

返回文章
返回